Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_provenance.
- NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_provenance.
- NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_assertion evidence source_evidence_literature NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_provenance.
- NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_assertion SIO_000772 17192482 NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_provenance.
- NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_assertion wasDerivedFrom befree-2016 NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_provenance.
- NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_assertion wasGeneratedBy ECO_0000203 NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_provenance.
- befree-2016 importedOn "2016-02-19" NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_provenance.